The North America and Europe medical display market size was valued at $1,010.5 million in 2018 and is expected to reach $1,515.8 million by 2026 with a CAGR of 5.2% during the forecast period.
Report Code : A05030 | Pages : 218 | Category : Life Sciences
The global pregabalin market was valued at $1.6 billion in 2022, and is projected to reach $2.2 billion by 2032, growing at a CAGR of 3% from 2023 to 2032.
Report Code : A02320 | Pages : 289 | Category : Life Sciences
The Indonesia over-the-top market was valued at $870.35 million in 2020, and is projected to reach $16,386.82 million by 2031, registering a CAGR of 31.3% from 2022 to 2031.
Report Code : A05821 | Pages : 193 | Category : ICT & Media
The global yerba mate market was valued at $1.8 billion in 2022, and is projected to reach $2.9 billion by 2032, growing at a CAGR of 5.2% from 2023 to 2032.
Report Code : A07438 | Pages : 300 | Category : Food and Beverages
The U.S. mhealth device market accounted for $12.11 billion in 2019, and is expected to reach $53.25 billion by 2028, registering a CAGR of 19.6% from 2021 to 2028.
Report Code : A11325 | Pages : 167 | Category : Semiconductor and Electronics
The global chewable coffee market was valued at $236.5 million in 2023, and is projected to reach $567.5 million by 2033, growing at a CAGR of 9.2% from 2024 to 2033.
Report Code : A299942 | Pages : 210 | Category : Food and Beverages
The Canada nootropics supplement market was valued at $86.3 million in 2022, and is projected to reach $156.8 million by 2032, growing at a CAGR of 6.4% from 2023 to 2032.
Report Code : A270649 | Pages : 89 | Category : Food and Beverages
The U.S. nootropics supplement market was valued at $657.2 million in 2022, and is projected to reach $1010.4 million by 2032, growing at a CAGR of 4.7% from 2023 to 2032.
Report Code : A270647 | Pages : 89 | Category : Food and Beverages
